Unexplained Findings of Kayser-Fleischer-Like Rings in a Patient with Cryptogenic Cirrhosis by Jawairia, Mahreema et al.
Hindawi Publishing Corporation
Case Reports in Gastrointestinal Medicine
Volume 2012, Article ID 438525, 3 pages
doi:10.1155/2012/438525
Case Report
UnexplainedFindingsof Kayser-Fleischer-LikeRings in
a Patient with CryptogenicCirrhosis
Mahreema Jawairia,MiralSubhani,GhulamSiddiqui,
ApsaraPrasad,GhulamullahShahzad, Kaleem Rizvon,andPaulMustacchia
Department of Medicine, Nassau University Medical Center, East Meadow, NY 11554, USA
Correspondence should be addressed to Ghulamullah Shahzad, shahzag@gmail.com
Received 30 November 2011; Accepted 4 January 2012
Academic Editors: O. I. Giouleme and A. J. Lembo
Copyright © 2012 Mahreema Jawairia et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Cryptogenic cirrhosis (CC) is deﬁned as cirrhosis occurring in an individual without an identiﬁable cause of liver disease, such
as excessive alcohol consumption, viral hepatitis infection, hemochromatosis, autoimmune hepatitis, primary biliary cirrhosis,
primary sclerosing cholangitis, chronic intake of medications that could induce cirrhosis, alpha-1-antitrypsin deﬁciency, Wilson’s
disease, or any other rare cause of cirrhosis according to the clinical context. Cryptogenic cirrhosis is a common cause of liver-
related morbidity and mortality in the United States. Nonalcoholic fatty liver disease is now recognized as the most common cause
of cryptogenic cirrhosis. A biopsy specimen is also important for detecting histological advanced disease, which may be clinically
silent and undetected by liver-related tests or diagnostic imaging. We are presenting an unusual case of a patient with cryptogenic
cirrhosis found to have Kayser-Fleischer-like rings without evidence of Wilson’s disease.
1.Introduction
Cirrhosis of liver is deﬁned as a chronic, progressive, diﬀuse
process, characterized by ﬁbrosis and structurally abnormal
nodules in liver. Cryptogenic cirrhosis is a chronic condition
of liver of unknown etiology. Cryptogenic cirrhosis accounts
for 5% to 30% of cases of cirrhosis and about 10% of liver
transplants [1, 2]. In the past, studies have shown that more
than half of such patients are female, the average age is
about 60 years, and they usually have only mild liver enzyme
abnormalities. Data exist to suggest that overweight is a risk
factor for chronic liver disease and that liver ﬁbrosis can
develop in overweight patients that are free of any other
known causes of chronic liver disease [3].
A study by Browning et al. hypothesized that nonal-
coholic steatohepatitis (NASH) associated with obesity and
diabetes mellitus (DM) is responsible for the majority of
cases of cryptogenic cirrhosis (CC) among Hispanics and
European Americans however, their ﬁndings also indicate
that this form of cirrhosis is rare among African Americans
[4].
2. Case Presentation
This is a 29 year-old Hispanic male with past medical history
of cryptogenic cirrhosis diagnosed in 2002 and morbid
obesity presenting with complaints of redness of left eye.
Physical examination revealed anicteric sclera, conjunctivitis
of left eye with a normal visual acuity of 20/20 in left eye.
Abdominal examination showed distention and mild ascites.
He also had bilateral edema and petechial hemorrhages in
lower extremities. Laboratory tests revealed anemia with a
hematocrit of 37%, severe thrombocytopenia with 44000
platelets, coagulopathy with a prolonged prothrombin time
of 20.3 seconds and elevated liver tests with total bilirubin
of 4mg/dL, AST of 59 International Units, ALT of 36 In-
ternational Units, and elevated alkaline phosphatase of 182.
Autoimmune workup was negative, alpha-1-antitrypsin and
serum ceruloplasmin levels were within normal limits and
24-hour urine copper was above the normal limit. Abdom-
inal ultrasound showed granular and nodular appearance
to the liver, compatible with the history of cirrhosis.
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Figure 1: Kayser-Fleischer ring.
pigmentation rings indistinguishable from Kayser-Fleischer
rings on slit lamp examination (Figure 1). He was given
artiﬁcial tears for dry eyes and was advised to stop wearing
contact lenses. He was discharged home to followup in GI
and ophthalmology clinic. When the patient followed up in
GI clinic, he was scheduled for repeat liver biopsy. The CT-
guided core biopsy result showed cirrhosis with 4+ iron in
sinusoidal pattern and liver copper level was 179 micrograms
per deciliter. Consequently, DNA testing for the C282Y and
H63D mutations in the HFE gene and genetic study for
ATP7B for Wilson’s disease were negative.
3. Discussion
Cirrhosis is usually accepted as “cryptogenic” only after
an extensive evaluation has omitted recognizable etiologies.
Obesity and Type 2 diabetes are the most prevalent risk
factors in cryptogenic cirrhosis. This suggests that many
patients with cryptogenic cirrhosis represent advanced non-
alcoholic steatohepatitis (NASH) [5]. Even though there is a
disparity in diagnosing cryptogenic cirrhosis among pathol-
ogists working with clinicians nevertheless, epidemiologic
datasupportNASHandsilentautoimmunehepatitisaslead-
ing causes of cryptogenic cirrhosis with regional variation
[6]. Liver transplantation remains the main treatment for
CC. CC has been reported to account for 3% to 31% of
patients with end-stage liver diseases, and it is among the
most common indications for orthotropic liver transplan-
tation [7]. Examining data from the United Network for
Organ Sharing registry, Nair et al. found a stepwise increase
in the diagnosis of CC with increasing BMI from 10% of
overweight patients to 15% of obese patients and 18% of
severely obese patients undergoing transplantation [8].
Kayser-Fleischer (K-F) rings are pigmented corneal rings
at the limbus of the cornea in Descemet’s membrane that
havebeendeemedpathognomonicofWilson’sdisease[9].In
1970, Harry and Tripathi described the electron microscopic
appearance of the K-F ring as electron-dense deposits of
copper of varying sizes lying mainly in the Descemet’s
membrane [10]. According to Frommer et al., three patients,
one with cryptogenic cirrhosis, one with active chronic
hepatitis, and one with neonatal hepatitis, were found to
havecornealpigmentationringsindistinguishablefromearly
K-F rings on slit lamp examination. These patients did not
have the clinical features of Wilson’s disease and their serum
copper and ceruloplasmin concentrations were normal [11].
Our patient also did not have the clinical features of Wil-
son’s disease and his serum copper and ceruloplasmin con-
centrations were normal as well. While his urinary copper
excretion was high, it was well below the level found in
symptomaticpatientswithWilson’sdisease.Theexactnature
of these rings could not be determined, and they were con-
sidered as K-F-like rings. Although K-F rings are considered
as pathognomonic of Wilson’s disease, they are seen in
any patient with unexplained central nervous system dis-
ease, poorly categorized psychiatric disorder, abnormal liver
function tests, chronic active hepatitis, cirrhosis of liver,
rickets, renal tubular acidosis, and unexplained Coomb’s
negative hemolytic anemia [12]. Hence, it is imperative for
the medical community to consider K-F rings in diﬀerential
diagnoses other than Wilson’s disease.
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